{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:43Z","timestamp":1792790503150,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/nm.3956","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T16:14:05Z","timestamp":1446480845000},"page":"1502-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins"],"prefix":"10.1038","volume":"21","author":[{"given":"Takuya","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tobiume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-8846","authenticated-orcid":false,"given":"Yasuko","family":"Tsunetsugu-Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"BFnm3956_CR1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JVI.78.3.1109-1120.2004","volume":"78","author":"E Bartee","year":"2004","unstructured":"Bartee, E., Mansouri, M., Hovey Nerenberg, B.T., Gouveia, K. & Fruh, K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109\u20131120 (2004).","journal-title":"J. Virol."},{"key":"BFnm3956_CR2","doi-asserted-by":"crossref","first-page":"14657","DOI":"10.1074\/jbc.M211285200","volume":"278","author":"E Goto","year":"2003","unstructured":"Goto, E. et al. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J. Biol. Chem. 278, 14657\u201314668 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR3","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1074\/jbc.M112.448209","volume":"288","author":"B van de Kooij","year":"2013","unstructured":"van de Kooij, B. et al. Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1. J. Biol. Chem. 288, 6617\u20136628 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR4","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1242\/jcs.119909","volume":"126","author":"H Fujita","year":"2013","unstructured":"Fujita, H., Iwabu, Y., Tokunaga, K. & Tanaka, Y. Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor. J. Cell Sci. 126, 2798\u20132809 (2013).","journal-title":"J. Cell Sci."},{"key":"BFnm3956_CR5","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.1205246109","volume":"109","author":"R Chen","year":"2012","unstructured":"Chen, R., Li, M., Zhang, Y., Zhou, Q. & Shu, H.B. The E3 ubiquitin ligase MARCH8 negatively regulates IL-1\u03b2-induced NF-\u03baB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc. Natl. Acad. Sci. USA 109, 14128\u201314133 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3956_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.177.1.341","volume":"177","author":"M Ohmura-Hoshino","year":"2006","unstructured":"Ohmura-Hoshino, M. et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 177, 341\u2013354 (2006).","journal-title":"J. Immunol."},{"key":"BFnm3956_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1084\/jem.20092203","volume":"208","author":"LE Tze","year":"2011","unstructured":"Tze, L.E. et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10\u2013driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149\u2013165 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm3956_CR8","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.74.11.5300-5309.2000","volume":"74","author":"S Ishido","year":"2000","unstructured":"Ishido, S., Wang, C., Lee, B.S., Cohen, G.B. & Jung, J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma\u2013associated herpesvirus K3 and K5 proteins. J. Virol. 74, 5300\u20135309 (2000).","journal-title":"J. Virol."},{"key":"BFnm3956_CR9","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1073\/pnas.140129797","volume":"97","author":"L Coscoy","year":"2000","unstructured":"Coscoy, L. & Ganem, D. Kaposi's sarcoma\u2013associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97, 8051\u20138056 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3956_CR10","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.150240097","volume":"97","author":"PG Stevenson","year":"2000","unstructured":"Stevenson, P.G., Efstathiou, S., Doherty, P.C. & Lehner, P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97, 8455\u20138460 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3956_CR11","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1074\/jbc.M805736200","volume":"284","author":"N Lapaque","year":"2009","unstructured":"Lapaque, N., Jahnke, M., Trowsdale, J. & Kelly, A.P. The HLA-DR\u03b1 chain is modified by polyubiquitination. J. Biol. Chem. 284, 7007\u20137016 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR12","doi-asserted-by":"crossref","first-page":"e15132","DOI":"10.1371\/journal.pone.0015132","volume":"5","author":"E Bartee","year":"2010","unstructured":"Bartee, E. et al. Membrane-associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes. PLoS ONE 5, e15132 (2010).","journal-title":"PLoS ONE"},{"key":"BFnm3956_CR13","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1091\/mbc.e10-11-0874","volume":"22","author":"CA Eyster","year":"2011","unstructured":"Eyster, C.A. et al. MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation. Mol. Biol. Cell 22, 3218\u20133230 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"BFnm3956_CR14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","volume":"113","author":"RS Harris","year":"2003","unstructured":"Harris, R.S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803\u2013809 (2003).","journal-title":"Cell"},{"key":"BFnm3956_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646\u2013650 (2002).","journal-title":"Nature"},{"key":"BFnm3956_CR16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau, M. et al. The cytoplasmic body component TRIM5\u03b1 restricts HIV-1 infection in Old World monkeys. Nature 427, 848\u2013853 (2004).","journal-title":"Nature"},{"key":"BFnm3956_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","volume":"3","author":"N Van Damme","year":"2008","unstructured":"Van Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245\u2013252 (2008).","journal-title":"Cell Host Microbe"},{"key":"BFnm3956_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJ Neil","year":"2008","unstructured":"Neil, S.J., Zang, T. & Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425\u2013430 (2008).","journal-title":"Nature"},{"key":"BFnm3956_CR19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","volume":"474","author":"N Laguette","year":"2011","unstructured":"Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell\u2013specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654\u2013657 (2011).","journal-title":"Nature"},{"key":"BFnm3956_CR20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","volume":"474","author":"K Hrecka","year":"2011","unstructured":"Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658\u2013661 (2011).","journal-title":"Nature"},{"key":"BFnm3956_CR21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2013.08.015","volume":"14","author":"Z Liu","year":"2013","unstructured":"Liu, Z. et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14, 398\u2013410 (2013).","journal-title":"Cell Host Microbe"},{"key":"BFnm3956_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature12653","volume":"502","author":"M Kane","year":"2013","unstructured":"Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563\u2013566 (2013).","journal-title":"Nature"},{"key":"BFnm3956_CR23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12542","volume":"502","author":"C Goujon","year":"2013","unstructured":"Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559\u2013562 (2013).","journal-title":"Nature"},{"key":"BFnm3956_CR24","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1073\/pnas.0809536106","volume":"106","author":"HC Yang","year":"2009","unstructured":"Yang, H.C., Shen, L., Siliciano, R.F. & Pomerantz, J.L. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc. Natl. Acad. Sci. USA 106, 6321\u20136326 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3956_CR25","doi-asserted-by":"crossref","first-page":"28779","DOI":"10.1074\/jbc.M112.381541","volume":"287","author":"M Jahnke","year":"2012","unstructured":"Jahnke, M., Trowsdale, J. & Kelly, A.P. Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) protein E3 ligases. J. Biol. Chem. 287, 28779\u201328789 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.chom.2014.10.014","volume":"16","author":"M Mashiba","year":"2014","unstructured":"Mashiba, M., Collins, D.R., Terry, V.H. & Collins, K.L. Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production. Cell Host Microbe 16, 722\u2013735 (2014).","journal-title":"Cell Host Microbe"},{"key":"BFnm3956_CR27","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1128\/JVI.02333-14","volume":"88","author":"C Haller","year":"2014","unstructured":"Haller, C. et al. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J. Virol. 88, 14241\u201314257 (2014).","journal-title":"J. Virol."},{"key":"BFnm3956_CR28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/cl.1.3.16708","volume":"1","author":"A Tokarev","year":"2011","unstructured":"Tokarev, A. & Guatelli, J. Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. Cell. Logist. 1, 90\u2013102 (2011).","journal-title":"Cell. Logist."},{"key":"BFnm3956_CR29","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1128\/JVI.75.15.6776-6785.2001","volume":"75","author":"K Tokunaga","year":"2001","unstructured":"Tokunaga, K. et al. Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J. Virol. 75, 6776\u20136785 (2001).","journal-title":"J. Virol."},{"key":"BFnm3956_CR30","doi-asserted-by":"crossref","first-page":"13072","DOI":"10.1128\/JVI.78.23.13072-13081.2004","volume":"78","author":"HM Pham","year":"2004","unstructured":"Pham, H.M., Arga\u00f1araz, E.R., Groschel, B., Trono, D. & Lama, J. Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes. J. Virol. 78, 13072\u201313081 (2004).","journal-title":"J. Virol."},{"key":"BFnm3956_CR31","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","volume":"77","author":"M Wiznerowicz","year":"2003","unstructured":"Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957\u20138961 (2003).","journal-title":"J. Virol."},{"key":"BFnm3956_CR32","doi-asserted-by":"crossref","first-page":"35060","DOI":"10.1074\/jbc.M109.058305","volume":"284","author":"Y Iwabu","year":"2009","unstructured":"Iwabu, Y. et al. HIV-1 accessory protein Vpu internalizes cell-surface BST-2\/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284, 35060\u201335072 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR33","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.1128\/JVI.77.19.10645-10650.2003","volume":"77","author":"M Tobiume","year":"2003","unstructured":"Tobiume, M., Lineberger, J.E., Lundquist, C.A., Miller, M.D. & Aiken, C. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 77, 10645\u201310650 (2003).","journal-title":"J. Virol."},{"key":"BFnm3956_CR34","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1128\/JVI.79.10.5996-6004.2005","volume":"79","author":"M Kinomoto","year":"2005","unstructured":"Kinomoto, M. et al. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor. J. Virol. 79, 5996\u20136004 (2005).","journal-title":"J. Virol."},{"key":"BFnm3956_CR35","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/nar\/gkm181","volume":"35","author":"M Kinomoto","year":"2007","unstructured":"Kinomoto, M. et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955\u20132964 (2007).","journal-title":"Nucleic Acids Res."},{"key":"BFnm3956_CR36","doi-asserted-by":"crossref","first-page":"12170","DOI":"10.1128\/JVI.05554-11","volume":"85","author":"T Daito","year":"2011","unstructured":"Daito, T. et al. A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region. J. Virol. 85, 12170\u201312178 (2011).","journal-title":"J. Virol."},{"key":"BFnm3956_CR37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/JVI.61.1.209-213.1987","volume":"61","author":"A Adachi","year":"1987","unstructured":"Adachi, A. et al. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61, 209\u2013213 (1987).","journal-title":"J. Virol."},{"key":"BFnm3956_CR38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.3646751","volume":"236","author":"Y Koyanagi","year":"1987","unstructured":"Koyanagi, Y. et al. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819\u2013822 (1987).","journal-title":"Science"},{"key":"BFnm3956_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virol.2007.11.033","volume":"373","author":"Y Kitagawa","year":"2008","unstructured":"Kitagawa, Y. et al. Inhibitory function of adapter-related protein complex 2 \u03b2 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome. Virology 373, 171\u2013180 (2008).","journal-title":"Virology"},{"key":"BFnm3956_CR40","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/088922299310223","volume":"15","author":"N Mochizuki","year":"1999","unstructured":"Mochizuki, N. et al. An infectious DNA clone of HIV type 1 subtype C. AIDS Res. Hum. Retroviruses 15, 1321\u20131324 (1999).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm3956_CR41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JVI.64.2.742-747.1990","volume":"64","author":"R Shibata","year":"1990","unstructured":"Shibata, R. et al. Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J. Virol. 64, 742\u2013747 (1990).","journal-title":"J. Virol."},{"key":"BFnm3956_CR42","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1128\/JVI.62.12.4691-4696.1988","volume":"62","author":"YM Naidu","year":"1988","unstructured":"Naidu, Y.M. et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62, 4691\u20134696 (1988).","journal-title":"J. Virol."},{"key":"BFnm3956_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193\u2013199 (1991).","journal-title":"Gene"},{"key":"BFnm3956_CR44","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1093\/emboj\/16.15.4531","volume":"16","author":"RA Fouchier","year":"1997","unstructured":"Fouchier, R.A., Meyer, B.E., Simon, J.H., Fischer, U. & Malim, M.H. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16, 4531\u20134539 (1997).","journal-title":"EMBO J."},{"key":"BFnm3956_CR45","doi-asserted-by":"crossref","first-page":"35350","DOI":"10.1074\/jbc.M110.173286","volume":"285","author":"Y Iwabu","year":"2010","unstructured":"Iwabu, Y. et al. Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. J. Biol. Chem. 285, 35350\u201335358 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm3956_CR46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0960-9822(99)80283-8","volume":"9","author":"TM Ross","year":"1999","unstructured":"Ross, T.M., Oran, A.E. & Cullen, B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9, 613\u2013621 (1999).","journal-title":"Curr. Biol."},{"key":"BFnm3956_CR47","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.0610291104","volume":"104","author":"B Dong","year":"2007","unstructured":"Dong, B. et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. USA 104, 1655\u20131660 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3956_CR48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"BFnm3956_CR49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.micinf.2014.06.004","volume":"16","author":"M Nomaguchi","year":"2014","unstructured":"Nomaguchi, M., Doi, N. & Adachi, A. Virological characterization of HIV-2 vpx gene mutants in various cell systems. Microbes Infect. 16, 695\u2013701 (2014).","journal-title":"Microbes Infect."},{"key":"BFnm3956_CR50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.onc.1209831","volume":"26","author":"C Nakai-Murakami","year":"2007","unstructured":"Nakai-Murakami, C. et al. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene 26, 477\u2013486 (2007).","journal-title":"Oncogene"},{"key":"BFnm3956_CR51","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.4049\/jimmunol.153.12.5826","volume":"153","author":"K Otake","year":"1994","unstructured":"Otake, K. et al. The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. J. Immunol. 153, 5826\u20135837 (1994).","journal-title":"J. Immunol."},{"key":"BFnm3956_CR52","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1128\/JVI.67.8.5056-5061.1993","volume":"67","author":"F Maldarelli","year":"1993","unstructured":"Maldarelli, F., Chen, M.Y., Willey, R.L. & Strebel, K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67, 5056\u20135061 (1993).","journal-title":"J. Virol."},{"key":"BFnm3956_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-4690-10-21","volume":"10","author":"T Koyama","year":"2013","unstructured":"Koyama, T., Sun, B., Tokunaga, K., Tatsumi, M. & Ishizaka, Y. DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition. Retrovirology 10, 21 (2013).","journal-title":"Retrovirology"},{"key":"BFnm3956_CR54","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1128\/JVI.69.7.4544-4547.1995","volume":"69","author":"Y Tsunetsugu-Yokota","year":"1995","unstructured":"Tsunetsugu-Yokota, Y. et al. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J. Virol. 69, 4544\u20134547 (1995).","journal-title":"J. Virol."},{"key":"BFnm3956_CR55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","volume":"139","author":"D Perez-Caballero","year":"2009","unstructured":"Perez-Caballero, D. et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499\u2013511 (2009).","journal-title":"Cell"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3956","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3956.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T18:22:16Z","timestamp":1692123736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnm3956"],"URL":"https:\/\/doi.org\/10.1038\/nm.3956","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]},"assertion":[{"value":"1 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}